February 6th 2023
The US Food and Drug Administration has accepted the Biologics License Application (BLA) for a proposed biosimilar of denosumab (Prolia and Xgeva; Amgen) for treatment of various conditions.
September 13th 2022
Radiofrequency echographic multi-spectrometry for diagnosing osteoporosis
December 22nd 2020A European multicenter clinical study that evaluated the diagnostic accuracy of radiofrequency echographic multi-spectrometry (REMS) for osteoporosis has concluded that both REMS sensitivity and specificity are over 90%, when using the current clinical reference technology of dual-energy x-ray absorptiometry (DXA).
Read More
Impact of blood flow restriction on bone markers during resistance training
December 17th 2020A 12-week course of low-intensity resistance training in postmenopausal women with osteoporosis or osteopenia was found safe and an effective method to improve muscle strength, bone formation markers and balance, according to a study in the Journal of Exercise Science and Fitness.
Read More
Vitamin K’s impact on bone mineral density and osteoporosis shows mixed results
November 19th 2020A literature review has concluded that, although some studies find that vitamin K might increase bone mineral density (BMD) and reduce fracture risk in people with osteoporosis, the potential benefits of vitamin K supplements are not sufficiently supported.
Read More
Low BMD linked to periodontitis in perimenopausal women
August 10th 2020A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.
Read More
Impact of exercise on bone mass with caloric restriction
June 2nd 2020Physical training can preserve and even significantly bolster the bone mass of the hip and femoral neck in individuals under caloric restriction, according to a systematic review and meta-analysis of 13 randomized clinical trials.
Read More
Patient performance indicators to measure effectiveness of fracture liaison services
May 12th 2020Nearly a dozen patient-level key performance indicators (KPIs) for fracture liaison services (FLSs) to guide quality improvement have been selected by the International Osteoporosis Foundation (IOF) Capture the Fracture campaign, in collaboration with the Fragility Fracture Network (FFN) and National Osteoporosis Foundation (NOF).
Read More
Joint statement on menopausal symptoms, osteoporosis after gynecological cancer
March 17th 2020Because all gynecological cancers are not the same, women surviving gynecological cancer should be able to access individualized therapies, according to the European Menopause and Andropause Society (EMAS) and the International Gynecologic Cancer Society (IGCS).
Read More
Soft drink consumption and osteoporotic fractures
November 8th 2019A prospective study published in Menopause has found that postmenopausal women who consume the equivalent of more than two 12-oz servings of soft drinks per day are at a significantly higher risk of hip fracture than postmenopausal women who drink less than one serving a day.
Read More
Imaging technique validated to evaluate bone marrow changes
November 8th 2019The diagnostic capability of diffusion-weighted magnetic resonance imaging (DWI) to assess vertebral marrow changes in postmenopausal women with osteoporosis has been confirmed by a prospective study published in La radiologia medica and it may be a safer alternative to DEXA.
Read More